Daniel Rico

Daniel Rico

Auto-generated profile, based on publicly available information

Daniel Rico

Biosciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in Cell
Verified
Journal Article
Open access
WAWilliam J. Astle
William J. Astle
HEHeather Elding
Heather Elding
TJTao Jiang
Tao Jiang
DADave Allen
Dave Allen
DRDace Ruklisa
Dace Ruklisa
NSNicole Soranzo
Nicole Soranzo
Many common variants have been associated with hematological traits, but identification of causal genes and pathways has proven challenging. We performed a genome-wide association analysis in the UK Biobank and INTERVAL studies, testing 29.5 million genetic variants for association with 36 red cell, white cell, and platelet properties in 173,480 European-ancestry participants. This effort yielded hundreds of low frequency (<5%) and rare (<1%) variants with a strong impact on blood cell phenotypes. Our data highlight general properties of the allelic architecture of complex traits, including the proportion of the heritable component of each blood trait explained by the polygenic signal across different genome regulatory domains. Finally, through Mendelian randomization, we provide evidence of shared genetic pathways linking blood cell indices with complex pathologies, including autoimmune diseases, schizophrenia, and coronary heart disease and evidence suggesting previously reported population associations between blood cell indices and cardiovascular disease may be non-causal.

1 July 2010 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
JRJuan-Carlos Rodríguez-Prados
Juan-Carlos Rodríguez-Prados
PTPaqui G. Través
Paqui G. Través
JCJimena Cuenca
Jimena Cuenca
DRDaniel Rico
Daniel Rico
JAJulian Aragones
Julian Aragones
Lisardo BoscáLisardo Boscá
Lisardo Boscá
Macrophages play a relevant role in innate and adaptive immunity depending on the balance of the stimuli received. From an analytical and functional point of view, macrophage stimulation can be segregated into three main modes, as follows: innate, classic, and alternative pathways. These differential activations result in the expression of specific sets of genes involved in the release of pro- or anti-inflammatory stimuli. In the present work, we have analyzed whether specific metabolic patterns depend on the signaling pathway activated. A [1,2-13C2]glucose tracer-based metabolomics approach has been used to characterize the metabolic flux distributions in macrophages stimulated through the classic, innate, and alternative pathways. Using this methodology combined with mass isotopomer distribution analysis of the new formed metabolites, the data show that activated macrophages are essentially glycolytic cells, and a clear cutoff between the classic/innate activation and the alternative pathway exists. Interestingly, macrophage activation through LPS/IFN-γ or TLR-2, -3, -4, and -9 results in similar flux distribution patterns regardless of the pathway activated. However, stimulation through the alternative pathway has minor metabolic effects. The molecular basis of the differences between these two types of behavior involves a switch in the expression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFK2) from the liver type-PFK2 to the more active ubiquitous PFK2 isoenzyme, which responds to Hif-1α activation and increases fructose-2,6-bisphosphate concentration and the glycolytic flux. However, using macrophages targeted for Hif-1α, the switch of PFK2 isoenzymes still occurs in LPS/IFN-γ–activated macrophages, suggesting that this pathway regulates ubiquitous PFK2 expression through Hif-1α-independent mechanisms.

1 November 2016 in Cell
Verified
Journal Article
Open access
LCLu Chen
Lu Chen
BGBing Ge
Bing Ge
FCFrancesco Paolo Casale
Francesco Paolo Casale
LVLouella Vasquez
Louella Vasquez
TKTony Kwan
Tony Kwan
NSNicole Soranzo
Nicole Soranzo
Characterizing the multifaceted contribution of genetic and epigenetic factors to disease phenotypes is a major challenge in human genetics and medicine. We carried out high-resolution genetic, epigenetic, and transcriptomic profiling in three major human immune cell types (CD14+ monocytes, CD16+ neutrophils, and naive CD4+ T cells) from up to 197 individuals. We assess, quantitatively, the relative contribution of cis-genetic and epigenetic factors to transcription and evaluate their impact as potential sources of confounding in epigenome-wide association studies. Further, we characterize highly coordinated genetic effects on gene expression, methylation, and histone variation through quantitative trait locus (QTL) mapping and allele-specific (AS) analyses. Finally, we demonstrate colocalization of molecular trait QTLs at 345 unique immune disease loci. This expansive, high-resolution atlas of multi-omics changes yields insights into cell-type-specific correlation between diverse genomic inputs, more generalizable correlations between these inputs, and defines molecular events that may underpin complex disease risk.

14 October 2012 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
MKMarta Kulis
Marta Kulis
SHSimon Heath
Simon Heath
MBMarina Bibikova
Marina Bibikova
AQAna C Queirós
Ana C Queirós
ANAlba Navarro
Alba Navarro
JMJosé I Martín-Subero
José I Martín-Subero

1 November 2016 in Cell
Verified
Journal Article
Closed access
HSHendrik G. Stunnenberg
Hendrik G. Stunnenberg
SASergio Abrignani
Sergio Abrignani
DADavid Adams
David Adams
MAMelanie de Almeida
Melanie de Almeida
LALucia Altucci
Lucia Altucci
MHMartin Hirst
Martin Hirst

8 June 2015 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
MKMarta Kulis
Marta Kulis
AMAngelika Merkel
Angelika Merkel
SHSimon Heath
Simon Heath
AQAna C Queirós
Ana C Queirós
RSRonald P Schuyler
Ronald P Schuyler
JMJosé I Martín-Subero
José I Martín-Subero